Chargement en cours...
Severe hypercalcemia and hypernatremia in a patient treated with canagliflozin
Drugs that inhibit the sodium-glucose co-transporter-2 (SGLT2) are an exciting novel, insulin-independent treatment for diabetes that block glucose reabsorption from the proximal tubules of the kidney, leading to increased glucose excretion and lower blood glucose levels. Inhibition of SGLT2 activit...
Enregistré dans:
| Publié dans: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bioscientifica Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4501313/ https://ncbi.nlm.nih.gov/pubmed/26191411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-15-0042 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|